Apoptosis in thalassemia major reduced by a butyrate derivative

Acta Haematologica

Volumn 114, Issue 3, 2005, Pages 155-159

  El Beshlawy, A ^a   Seoud, H ^a   Ibrahim, A ^a   Youssry, I ^a,c   Gabre, H ^a   Isma'eel, H ^b   Aoun, E ^b   Taher, A ^b  

^a AL AZHAR UNIVERSITY   (Egypt)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^c NONE   (Egypt)

Author keywords

Apoptosis; L Carnitine; Thalassemia

Indexed keywords

BUTYRIC ACID DERIVATIVE; CARNITINE; HEMOGLOBIN;

ADOLESCENT; ADULT; AGAR GEL ELECTROPHORESIS; APOPTOSIS; ARTICLE; BLOOD TRANSFUSION; BONE MARROW; CHILD; CLINICAL ARTICLE; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROBLAST; ERYTHROID PRECURSOR CELL; FEMALE; HUMAN; HUMAN CELL; MALE; NUCLEOSOME; PHOTOMETRY; PRIORITY JOURNAL; THALASSEMIA MAJOR; TIME SERIES ANALYSIS;

ADOLESCENT; APOPTOSIS; BETA-THALASSEMIA; BONE MARROW CELLS; CARNITINE; CHILD; CHILD, PRESCHOOL; DNA FRAGMENTATION; ERYTHROBLASTS; FEMALE; HEMATOLOGIC AGENTS; HUMANS; MALE; NUCLEOSOMES;

EID: 27544462407     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087890     Document Type: Article

References (30)

1. Weatherall DJ: Overview: Mechanism for the heterogeneity of the thalassemia. Int J Pediatr Hematol Oncol 1997;4:3-10.
2. Shiner E, Rachmilewitz EA: Oxidative denaturation of red blood cells in thalassemia. Semin Hematol 1990;27:70-76.
3. Howie SEM, Harrison DJ, Wyllie AH: Lymphocyte apoptosis. Mechanisms and implications in disease. Immunol Rev 1994;141:142-156.
4. Pootrakul P, Sirankapracha P, Hemsorach S, Schrier S: A correlation of erythrokinetics, ineffective erythropoiesis and erythroid precursors apoptosis in Thai patients with thalassemia. Blood 2000;96:2606-2612.
5. Yuan J, Anglucci E, Lucarelli G: Accelerated programmed cell death in erythroid precursors of patients with severe β-thalassemia. Blood 1993;82:374-377.
6. Hockenbory DM, Zoltan N, Xiao Ming Y: Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993;75:241-251.
7. Rudin CM, Rhompson CB: Apoptosis and disease: Regulation and clinical relevance of programmed cell death. Annu Rev Med 1997;48:267-281.
8. Walter H: L-Carnitine. Arch Dis Child 1996;74:475-478.
9. Perrine SP, Ginder GD, Faller DV: A short-term trial of butyrate to stimulate fetal-globin gene expression in the β-globin disorder. N Engl J Med 1993;328:81-85.
10. Smith R, Li J, Noguchi C, Schechter A: Quantitative PCR analysis of HbF inducers in primary human adult erythroid cells. Blood 2000;95:863-869.
11. Palmieri L, Ronca F, Malengo S, Bertelli A: Protection of β-thalassemia erythrocytes from oxidative stress by propionyl carnitine. Int J Tiss React 1994;16:121-129.
12. Fritz IB, Arrigoni Martelli E: Sites of action of carnitine and its derivatives on cardiovascular system. Trends Pharmacol Sci 1995;14:355-360.
13. Yesilipek M, Volken H, Okay Y: L-Carnitine treatment in β-thalassemia major. Acta Haematol 1998;100:162-163.
14. Andrieu A, Nafferzon J, Hatem S: L-Carnitine prevents doxorubicin-induced apoptosis of cardiac myocytes: Role of inhibition of ceramide generation. FASEB J 1999;13:1501-1510.
15. Cifore M, Alene E, Dimarizo L, Ruggeni B: Effect of L-carnitine treatment on in vivo apoptosis and ceramide generation in PB lymphocytes from AIDS patients. Proc Assoc Am Physicians 1997;109:146-153.
16. Sellins A, Cohen H: Gene induction by irradiation leads to DNA fragmentation in lymphocytes. J Immunol 1987;135:1399-1420.
17. Armitage P, Berry G: Statistical Methods in Medical Research, ed 3. Oxford, Blackwell Scientific, 1994.
18. Cantis F, Tabelline L, Lucarelli G, Buffi O, Tonucci P, Persine B: The importance of erythroid expansion in detecting the extent of apoptosis in erythroid precursors in patients with β-thalassemia. Blood 2000;96:3624-3629.
19. El Beshlawy A, El Saiedi S, Abd El Raouf E: L-Carnitine and cardiac functions in Egyptian thalassemics. Proc 4th Conf Echocardiography and Vascular Ultrasound, Cairo 2000, pp 157-162.
20. Faller DV, Perrine SP: Butyrate in the treatment of sickle cell disease and β-thalassemia. Curr Opin Hematol 1995;2:109-117.
21. Pons R, Devivo DC: Primary and secondary carnitine deficiency syndromes. J Child Neurol 1995;110(suppl): 258-262.
22. Calvani M, Benatti P, Mancinelli A, D'Iddio S, Giordano V, Koverech A, Amato A, Brass EP: Carnitine replacement in end-stage renal disease and hemodialysis. Ann NY Acad Sci 2004;1033:52-66.
23. Ronca F, Palmieri L, Malengo S, Bertelli A: Effect of L-propionyl carnitine on in vitro membrane alteration of sickle-cell anaemia erythrocytes. Int J Tissue React 1994;16:187-194.
24. Thompson C: Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-1462.
25. De Maria R, Testa U, Luchetti L, Zeuner A, Stassi G: Apoptotic role of Fas/Fas ligand system in the regulation of erythropoiesis. Blood 1999;93:796-803.
26. Dimarizo L, Moretti S, Zazzeron F: Acetyl L-carnitine administration increase insulin-like growth factor-1 levels in a symptomatic HIV-1 infected subjects, correlation with its suppressive effect on lymphocyte apoptosis and ceramide generation. Clin Immunol 1999;92:103-110.
27. Gutteridge JM, Hallwell B: Iron toxicity and oxygen radicals. Clin Hematol 1989;2:195-256.
28. Tsagris V, Liapi-Adamidou G: Serum carnitine levels in patients with homozygous β-thalassemia: A possible new role for carnitine? Eur J Pediatr 2005;164:131-134.
29. El-Beshlawy A, Ragab L, Fattah AA, Ibrahim IY, Hamdy M, Makhlouf A, Aoun E, Hoffbrand V, Taher A: Improvement of cardiac function in thalassemia major treated with L-carnitine. Acta Haematol 2004;111:143-148.
30. Tein I, De Vivo DC, Bierman F, Pulver P, De Meirleir LJ, Cvitanovic-Sojat L, Pagon RA, Bertini E, Dionisi-Vici C, Servidei S, et al: Impaired skin fibroblast carnitine uptake in primary systemic carnitine deficiency manifested by childhood carnitine-responsive cardiomyopathy. Pediatr Res 1990;28:247-255.